Market capitalization | $141.33b |
Enterprise Value | $199.36b |
P/E (TTM) P/E ratio | 33.53 |
EV/FCF (TTM) EV/FCF | 24.23 |
EV/Sales (TTM) EV/Sales | 3.32 |
P/S ratio (TTM) P/S ratio | 2.35 |
P/B ratio (TTM) P/B ratio | 1.53 |
Dividend yield | 6.62% |
Last dividend (FY23) | $1.65 |
As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.
27 Analysts have issued a Pfizer forecast:
27 Analysts have issued a Pfizer forecast:
Sep '24 |
+/-
%
|
||
Revenue | 60,113 60,113 |
12%
12%
|
|
Gross Profit | 35,169 35,169 |
3%
3%
|
|
EBITDA | 16,705 16,705 |
0%
0%
|
EBIT (Operating Income) EBIT | 9,813 9,813 |
7%
7%
|
Net Profit | 4,273 4,273 |
59%
59%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.
Head office | United States |
CEO | Albert Bourla |
Employees | 88,000 |
Founded | 1849 |
Website | www.pfizer.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.